MADRIGAL PHARMACEUTICALS INC (MDGL) Stock Analyst Ratings
NASDAQ:MDGL - Nasdaq - US5588681057 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 82% to MDGL. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 388.42. This target is 15.52% above the current price.
MDGL was analyzed by 22 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about MDGL.
In the previous month the buy percentage consensus was at a similar level.
MDGL was analyzed by 22 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-01-14 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-01-10 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2024-11-20 | Cantor Fitzgerald | Reiterate | Neutral |
| 2024-11-05 | B. Riley Securities | Maintains | Neutral -> Neutral |
| 2024-11-01 | UBS | Maintains | Buy -> Buy |
| 2024-10-23 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-10-22 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-11 | Cantor Fitzgerald | Reiterate | Neutral |
| 2024-08-08 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2024-08-08 | Citigroup | Maintains | Buy -> Buy |
| 2024-07-23 | Cantor Fitzgerald | Reiterate | Neutral |
| 2024-07-16 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2024-06-28 | Cantor Fitzgerald | Initiate | Neutral |
| 2024-06-11 | Wolfe Research | Initiate | Outperform |
| 2024-05-10 | B. Riley Securities | Maintains | Neutral -> Neutral |
| 2024-05-08 | JMP Securities | Maintains | Market Outperform -> Market Outperform |
| 2024-05-08 | Citigroup | Maintains | Buy -> Buy |
| 2024-05-08 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-04-22 | B of A Securities | Initiate | Underperform |
| 2024-03-20 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2024-03-15 | TD Cowen | Maintains | Outperform -> Outperform |
| 2024-03-15 | JMP Securities | Maintains | Outperform -> Outperform |
| 2024-03-15 | UBS | Maintains | Buy -> Buy |
| 2024-03-15 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-03-15 | B. Riley Securities | Upgrade | Sell -> Neutral |
| 2024-03-15 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-03-15 | Citigroup | Maintains | Buy -> Buy |
| 2024-03-15 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-03-14 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2024-03-12 | HC Wainwright & Co. | Maintains | Buy -> Buy |